Ultravist 240 and Gallbladder cancer stage iii - from FDA reports


There is no Gallbladder cancer stage iii reported by people who take Ultravist 240 yet. This review analyzes which people have Gallbladder cancer stage iii with Ultravist 240. It is created by eHealthMe based on reports from FDA, and is updated regularly.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our independent and original studies have been referenced on 400+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO.



On Aug, 21, 2018

No report is found.

Are you new to Ultravist 240 or have questions?

Volunteer or get paid to help people with your care experience



Related studies

Ultravist 240

Ultravist 240 has active ingredients of iopromide. (latest outcomes from Ultravist 240 55 users)

Gallbladder Cancer Stage Iii

Gallbladder cancer stage iii (cancer has spread through the thin layers of tissue that cover the gallbladder and/or to the liver and/or to one nearby organ) has been reported by people with hiv infection, crohn's disease, rheumatoid arthritis (latest reports from 8 Gallbladder cancer stage iii patients).


Drugs that are associated with Gallbladder cancer stage iii
Gallbladder cancer stage iii
Could your condition cause Gallbladder cancer stage iii
Gallbladder cancer stage iii
Ultravist 240 side effects
Browse all side effects of Ultravist 240
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Ultravist 240 and have Gallbladder cancer stage iii


You are not alone. Join our personalized support groups:


Recent updates

General studies

You could also:

  • Print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.